Literature DB >> 29359454

Repeatability and Reproducibility of the Ultrasonic Attenuation Coefficient and Backscatter Coefficient Measured in the Right Lobe of the Liver in Adults With Known or Suspected Nonalcoholic Fatty Liver Disease.

Aiguo Han1, Michael P Andre2, Lisa Deiranieh2, Elise Housman2, John W Erdman3, Rohit Loomba4, Claude B Sirlin5, William D O'Brien1.   

Abstract

OBJECTIVES: To assess the repeatability and reproducibility of the ultrasonic attenuation coefficient (AC) and backscatter coefficient (BSC) measured in the livers of adults with known or suspected nonalcoholic fatty liver disease (NAFLD).
METHODS: The Institutional Review Board approved this Health Insurance Portability and Accountability Act-compliant prospective study; informed consent was obtained. Forty-one research participants with known or suspected NAFLD were recruited and underwent same-day ultrasound examinations of the right liver lobe with a clinical scanner by a clinical sonographer. Each participant underwent 2 scanning trials, with participant repositioning between trials. Two transducers were used in each trial. For each transducer, machine settings were optimized by the sonographer but then kept constant while 3 data acquisitions were obtained from the liver without participant repositioning and then from an external calibrated phantom. Raw RF echo data were recorded. The AC and BSC were measured within 2.6 to 3.0 MHz from a user-defined hepatic field of interest from each acquisition. The repeatability and reproducibility were analyzed by random-effects models.
RESULTS: The mean AC and log-transformed BSC (logBSC) were 0.94 dB/cm-MHz and -27.0 dB, respectively. Intraclass correlation coefficients were 0.88 to 0.94 for the AC and 0.87 to 0.95 for the logBSC acquired without participant repositioning. For between-trial repeated scans with participant repositioning, the intraclass correlation coefficients were 0.80 to 0.84 for the AC and 0.69 to 0.82 for the logBSC after averaging results from 3 within-trial images. The variability introduced by the transducer was less than the repeatability error.
CONCLUSIONS: Hepatic AC and BSC measures using a reference phantom technique on a clinical scanner are repeatable and reproducible between transducers in adults with known or suspected NAFLD.
© 2018 by the American Institute of Ultrasound in Medicine.

Entities:  

Keywords:  fatty liver disease; gastrointestinal; repeatability; reproducibility; ultrasonic attenuation coefficient; ultrasonic backscatter coefficient; ultrasound techniques/physics

Mesh:

Year:  2018        PMID: 29359454      PMCID: PMC6056350          DOI: 10.1002/jum.14537

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  27 in total

1.  Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study.

Authors:  Rohit Loomba; Nicholas Schork; Chi-Hua Chen; Ricki Bettencourt; Ana Bhatt; Brandon Ang; Phirum Nguyen; Carolyn Hernandez; Lisa Richards; Joanie Salotti; Steven Lin; Ekihiro Seki; Karen E Nelson; Claude B Sirlin; David Brenner
Journal:  Gastroenterology       Date:  2015-08-20       Impact factor: 22.682

2.  A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease.

Authors:  Jeremy S Paige; Gregory S Bernstein; Elhamy Heba; Eduardo A C Costa; Marilia Fereirra; Tanya Wolfson; Anthony C Gamst; Mark A Valasek; Grace Y Lin; Aiguo Han; John W Erdman; William D O'Brien; Michael P Andre; Rohit Loomba; Claude B Sirlin
Journal:  AJR Am J Roentgenol       Date:  2017-03-07       Impact factor: 3.959

3.  The measurement of backscatter coefficient from a broadband pulse-echo system: a new formulation.

Authors:  X Chen; D Phillips; K Q Schwarz; J G Mottley; K J Parker
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  1997       Impact factor: 2.725

Review 4.  Intraclass correlations: uses in assessing rater reliability.

Authors:  P E Shrout; J L Fleiss
Journal:  Psychol Bull       Date:  1979-03       Impact factor: 17.737

5.  Development of an ultrasonic method to detect cervical remodeling in vivo in full-term pregnant women.

Authors:  Barbara L McFarlin; Jennifer Balash; Viksit Kumar; Timothy A Bigelow; Xavier Pombar; Jacques S Abramowicz; William D O'Brien
Journal:  Ultrasound Med Biol       Date:  2015-05-23       Impact factor: 2.998

6.  Repeatability and Reproducibility of a Clinically Based QUS Phantom Study and Methodologies.

Authors:  Aiguo Han; Michael P Andre; John W Erdman; Rohit Loomba; Claude B Sirlin; William D O'Brien
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2016-07-09       Impact factor: 2.725

7.  Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.

Authors:  Robert P Myers; Aaron Pollett; Richard Kirsch; Gilles Pomier-Layrargues; Melanie Beaton; Mark Levstik; Andres Duarte-Rojo; David Wong; Pam Crotty; Magdy Elkashab
Journal:  Liver Int       Date:  2012-03-21       Impact factor: 5.828

Review 8.  Quantitative imaging biomarkers: a review of statistical methods for technical performance assessment.

Authors:  David L Raunig; Lisa M McShane; Gene Pennello; Constantine Gatsonis; Paul L Carson; James T Voyvodic; Richard L Wahl; Brenda F Kurland; Adam J Schwarz; Mithat Gönen; Gudrun Zahlmann; Marina V Kondratovich; Kevin O'Donnell; Nicholas Petrick; Patricia E Cole; Brian Garra; Daniel C Sullivan
Journal:  Stat Methods Med Res       Date:  2014-06-11       Impact factor: 3.021

Review 9.  MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice.

Authors:  Parambir S Dulai; Claude B Sirlin; Rohit Loomba
Journal:  J Hepatol       Date:  2016-06-14       Impact factor: 25.083

10.  Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial.

Authors:  Thuy-Anh Le; Joshua Chen; Christopher Changchien; Michael R Peterson; Yuko Kono; Heather Patton; Benjamin L Cohen; David Brenner; Claude Sirlin; Rohit Loomba
Journal:  Hepatology       Date:  2012-07-02       Impact factor: 17.425

View more
  13 in total

1.  Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease by Using Quantitative US.

Authors:  Aiguo Han; Yingzhen N Zhang; Andrew S Boehringer; Vivian Montes; Michael P Andre; John W Erdman; Rohit Loomba; Mark A Valasek; Claude B Sirlin; William D O'Brien
Journal:  Radiology       Date:  2020-02-04       Impact factor: 11.105

2.  Low fat but not soy protein isolate was an effective intervention to reduce nonalcoholic fatty liver disease progression in C57BL/6J mice: monitored by a novel quantitative ultrasound (QUS) method.

Authors:  Joe L Rowles; Aiguo Han; Rita J Miller; Jamie R Kelly; Catherine C Applegate; Matthew A Wallig; William D O'Brien; John W Erdman
Journal:  Nutr Res       Date:  2018-12-14       Impact factor: 3.315

3.  Inter-platform reproducibility of ultrasonic attenuation and backscatter coefficients in assessing NAFLD.

Authors:  Aiguo Han; Yingzhen N Zhang; Andrew S Boehringer; Michael P Andre; John W Erdman; Rohit Loomba; Claude B Sirlin; William D O'Brien
Journal:  Eur Radiol       Date:  2019-02-19       Impact factor: 5.315

4.  A Phantom-Based Assessment of Repeatability and Reproducibility of Transvaginal Quantitative Ultrasound.

Authors:  Shi Chen; Barbara L McFarlin; Barbara T Meagher; Tara A Peters; Douglas G Simpson; William D O'Brien; Aiguo Han
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2019-06-14       Impact factor: 2.725

5.  Direct Comparison of Quantitative US versus Controlled Attenuation Parameter for Liver Fat Assessment Using MRI Proton Density Fat Fraction as the Reference Standard in Patients Suspected of Having NAFLD.

Authors:  Jinho Jung; Aiguo Han; Egbert Madamba; Ricki Bettencourt; Rohan R Loomba; Andrew S Boehringer; Michael P Andre; John W Erdman; William D O'Brien; Kathryn J Fowler; Claude B Sirlin; Rohit Loomba
Journal:  Radiology       Date:  2022-03-29       Impact factor: 29.146

6.  Attenuation Coefficient Parameter Computations for Tissue Composition Assessment of Carotid Atherosclerotic Plaque in Vivo.

Authors:  Catherine N Steffel; Shahriar Salamat; Thomas D Cook; Stephanie M Wilbrand; Robert J Dempsey; Carol C Mitchell; Tomy Varghese
Journal:  Ultrasound Med Biol       Date:  2020-04-11       Impact factor: 2.998

7.  Inter-sonographer reproducibility of quantitative ultrasound outcomes and shear wave speed measured in the right lobe of the liver in adults with known or suspected non-alcoholic fatty liver disease.

Authors:  Aiguo Han; Yassin Labyed; Ethan Z Sy; Andrew S Boehringer; Michael P Andre; John W Erdman; Rohit Loomba; Claude B Sirlin; William D O'Brien
Journal:  Eur Radiol       Date:  2018-06-04       Impact factor: 5.315

8.  Hepatic steatosis assessment using ultrasound homodyned-K parametric imaging: the effects of estimators.

Authors:  Zhuhuang Zhou; Qiyu Zhang; Weiwei Wu; Ying-Hsiu Lin; Dar-In Tai; Jeng-Hwei Tseng; Yi-Ru Lin; Shuicai Wu; Po-Hsiang Tsui
Journal:  Quant Imaging Med Surg       Date:  2019-12

9.  Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat with Radiofrequency Ultrasound Data Using One-dimensional Convolutional Neural Networks.

Authors:  Aiguo Han; Michal Byra; Elhamy Heba; Michael P Andre; John W Erdman; Rohit Loomba; Claude B Sirlin; William D O'Brien
Journal:  Radiology       Date:  2020-02-25       Impact factor: 29.146

Review 10.  Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease.

Authors:  Amir M Pirmoazen; Aman Khurana; Ahmed El Kaffas; Aya Kamaya
Journal:  Theranostics       Date:  2020-03-04       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.